Cargando…
Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817590/ https://www.ncbi.nlm.nih.gov/pubmed/32705308 http://dx.doi.org/10.1007/s00277-020-04181-5 |
| _version_ | 1783638671925182464 |
|---|---|
| author | Shahswar, Rabia Beutel, Gernot Gabdoulline, Razif Koenecke, Christian Markel, Dominik Eder, Matthias Stadler, Michael Gohring, Gudrun Schlegelberger, Brigitte Trummer, Arne Krauter, Juergen Thol, Felicitas Heuser, Michael |
| author_facet | Shahswar, Rabia Beutel, Gernot Gabdoulline, Razif Koenecke, Christian Markel, Dominik Eder, Matthias Stadler, Michael Gohring, Gudrun Schlegelberger, Brigitte Trummer, Arne Krauter, Juergen Thol, Felicitas Heuser, Michael |
| author_sort | Shahswar, Rabia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7817590 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78175902021-01-25 Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up Shahswar, Rabia Beutel, Gernot Gabdoulline, Razif Koenecke, Christian Markel, Dominik Eder, Matthias Stadler, Michael Gohring, Gudrun Schlegelberger, Brigitte Trummer, Arne Krauter, Juergen Thol, Felicitas Heuser, Michael Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2020-07-23 2021 /pmc/articles/PMC7817590/ /pubmed/32705308 http://dx.doi.org/10.1007/s00277-020-04181-5 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter to the Editor Shahswar, Rabia Beutel, Gernot Gabdoulline, Razif Koenecke, Christian Markel, Dominik Eder, Matthias Stadler, Michael Gohring, Gudrun Schlegelberger, Brigitte Trummer, Arne Krauter, Juergen Thol, Felicitas Heuser, Michael Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up |
| title | Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up |
| title_full | Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up |
| title_fullStr | Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up |
| title_full_unstemmed | Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up |
| title_short | Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up |
| title_sort | risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817590/ https://www.ncbi.nlm.nih.gov/pubmed/32705308 http://dx.doi.org/10.1007/s00277-020-04181-5 |
| work_keys_str_mv | AT shahswarrabia riskoftumorlysissyndromeinpatientswithacutemyeloidleukemiatreatedwithvenetoclaxcontainingregimenswithoutdoserampup AT beutelgernot riskoftumorlysissyndromeinpatientswithacutemyeloidleukemiatreatedwithvenetoclaxcontainingregimenswithoutdoserampup AT gabdoullinerazif riskoftumorlysissyndromeinpatientswithacutemyeloidleukemiatreatedwithvenetoclaxcontainingregimenswithoutdoserampup AT koeneckechristian riskoftumorlysissyndromeinpatientswithacutemyeloidleukemiatreatedwithvenetoclaxcontainingregimenswithoutdoserampup AT markeldominik riskoftumorlysissyndromeinpatientswithacutemyeloidleukemiatreatedwithvenetoclaxcontainingregimenswithoutdoserampup AT edermatthias riskoftumorlysissyndromeinpatientswithacutemyeloidleukemiatreatedwithvenetoclaxcontainingregimenswithoutdoserampup AT stadlermichael riskoftumorlysissyndromeinpatientswithacutemyeloidleukemiatreatedwithvenetoclaxcontainingregimenswithoutdoserampup AT gohringgudrun riskoftumorlysissyndromeinpatientswithacutemyeloidleukemiatreatedwithvenetoclaxcontainingregimenswithoutdoserampup AT schlegelbergerbrigitte riskoftumorlysissyndromeinpatientswithacutemyeloidleukemiatreatedwithvenetoclaxcontainingregimenswithoutdoserampup AT trummerarne riskoftumorlysissyndromeinpatientswithacutemyeloidleukemiatreatedwithvenetoclaxcontainingregimenswithoutdoserampup AT krauterjuergen riskoftumorlysissyndromeinpatientswithacutemyeloidleukemiatreatedwithvenetoclaxcontainingregimenswithoutdoserampup AT tholfelicitas riskoftumorlysissyndromeinpatientswithacutemyeloidleukemiatreatedwithvenetoclaxcontainingregimenswithoutdoserampup AT heusermichael riskoftumorlysissyndromeinpatientswithacutemyeloidleukemiatreatedwithvenetoclaxcontainingregimenswithoutdoserampup |